HALO logo
halo search icon
Corbus Pharmaceuticals Holdings Inc
Corbus Pharmaceuticals Holdings Inc
CRBP · NAS

Corbus Pharmaceuticals Holdings Inc

US$9.73

Price Arrow0.58 (6.34%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Corbus Pharmaceuticals Holdings Inc Overview

CRBP Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Weak

About CRBP

icon

Telephone

1.617.963.0100

icon

Address

500 River Ridge Drive, Norwood, MA 02062

Description

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.

CRBP Price Chart

Key Stats

Market Cap

US$169.53M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 6.72 - 20.56

Trade Value (12mth)

US$682,713.00

1 week

-17.04%

1 month

-11.12%

YTD

16.26%

1 year

23.48%

All time high

323.40

Key Fundamentals

EPS 3 yr Growth

-41.90%

EBITDA Margin

0.00%

Operating Cashflow

-$64m

Free Cash Flow Return

-44.20%

ROIC

-53.90%

Interest Coverage

0.00

Quick Ratio

8.10

Other Data

Shares Outstanding (Fully Diluted)

19m

HALO Sector

Healthcare

Next Company Report Date

15-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CRBP Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
13 May 26
13 May 26
13 May 26

CRBP Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-10.31-3.68-5.9locklocklock
EPS (Fully Diluted)
$locklocklocklock-10.31-3.68-5.9locklocklock
Growth
%locklocklocklock-1.564.3-60.1locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Corbus Pharmaceuticals Holdings Inc (CRBP:NAS)?
Halo FAQ
The current share price of Corbus Pharmaceuticals Holdings Inc (CRBP:NAS) is USD$9.73.
What is the 52-week high share price for Corbus Pharmaceuticals Holdings Inc (CRBP:NAS)?
Halo FAQ
The 52-week high share price for Corbus Pharmaceuticals Holdings Inc (CRBP:NAS) is USD$20.56.
What is the 52-week low share price for Corbus Pharmaceuticals Holdings Inc (CRBP:NAS)?
Halo FAQ
The 52-week low share price for Corbus Pharmaceuticals Holdings Inc (CRBP:NAS) is USD$6.72.
What is the dividend yield for Corbus Pharmaceuticals Holdings Inc (CRBP:NAS)?
Halo FAQ
Corbus Pharmaceuticals Holdings Inc (CRBP:NAS) does not pay a dividend.
What was Corbus Pharmaceuticals Holdings Inc (CRBP:NAS) last dividend payment?
Halo FAQ
Corbus Pharmaceuticals Holdings Inc (CRBP:NAS) does not pay a dividend.
What is the franking level for Corbus Pharmaceuticals Holdings Inc (CRBP:NAS)?
Halo FAQ
Corbus Pharmaceuticals Holdings Inc (CRBP:NAS) has a franking level of 0.00%.
In which sector is Corbus Pharmaceuticals Holdings Inc (CRBP:NAS) classified?
Halo FAQ
Corbus Pharmaceuticals Holdings Inc (CRBP:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.